William T. Burkoth - Net Worth and Insider Trading
William T. Burkoth Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, William T. Burkoth owns 2 companies in total, including NovoCure Ltd (NVCR) , and 4D Molecular Therapeutics Inc (FDMT) .
Click here to see the complete history of William T. Burkoth’s form 4 insider trades.
Insider Ownership Summary of William T. Burkoth
Ticker | Company | Transaction Date | Type of Owner |
---|---|---|---|
NVCR | NovoCure Ltd | 2015-10-01 | director |
FDMT | 4D Molecular Therapeutics Inc | 2020-12-10 | director |
William T. Burkoth Trading Performance
William T. Burkoth Ownership Network
Ownership Network List of William T. Burkoth
Ownership Network Relation of William T. Burkoth

William T. Burkoth Owned Company Details
What does NovoCure Ltd do?
Who are the key executives at NovoCure Ltd?
William T. Burkoth is the director of NovoCure Ltd. Other key executives at NovoCure Ltd include Chief Financial Officer Ashley Cordova , President & CNS Cancers US Frank X Leonard , and Chief Innovation Officer Uri Weinberg .
NovoCure Ltd (NVCR) Insider Trades Summary
Over the past 18 months, William T. Burkoth made no insider transaction in NovoCure Ltd (NVCR). Other recent insider transactions involving NovoCure Ltd (NVCR) include a net sale of 1,982 shares made by , a net sale of 37,794 shares made by Frank X Leonard , and a net sale of 29,729 shares made by Ashley Cordova .
In summary, during the past 3 months, insiders sold 80,540 shares of NovoCure Ltd (NVCR) in total and bought 0 shares, with a net sale of 80,540 shares. During the past 18 months, 98,116 shares of NovoCure Ltd (NVCR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 98,116 shares.
NovoCure Ltd (NVCR)'s detailed insider trading history can be found in Insider Trading Tracker table.
NovoCure Ltd Insider Transactions
William T. Burkoth Mailing Address
Above is the net worth, insider trading, and ownership report for William T. Burkoth. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, William T. Burkoth's mailing address is: New York Ny 10017.